Beginning the global COVID-19 vaccine rollout 100 days after the virus was sequenced could have saved more than 8 million lives by the end of 2021, most of them in lower- and middle-income countries, according to modelling evidence brought together in a new policy brief led by the United Nations University Institute for Water, Environment and Health (UNU-INWEH) and co-authored by members of the Pandemic Sciences Institute alongside colleagues from international institutions. The authors argue that fair vaccine-sharing rules should be established before the next pandemic, rather than negotiated during the crisis itself.
Best Practices in Global Vaccination Roll-Out to Reduce Health Inequity proposes an ‘equity-by-design’ framework that links vaccine development to financing, procurement, manufacturing, allocation, delivery, uptake, safety monitoring and accountability. It presents six recommendations as practical pillars for delivering on the WHO Pandemic Agreement, adopted in May 2025, and the amended International Health Regulations, in force for most States Parties since September 2025.
The 8 million estimate comes from a modelling study reviewed in the publication, which assumes that the public health measures followed their historical course. An earlier start would have allowed high vaccine coverage to be reached before the Delta variant spread. The brief is equally clear that speed alone is not enough: parallel investment in vaccine manufacturing and health system infrastructure could have saved a further 3 million lives.
The policy brief, accompanied by an Expert Review of Vaccines article led by PSI authors, highlights that COVID-19 vaccines were introduced across countries faster and more equitably than any earlier vaccine. Even so, access remained sharply unequal. By the end of 2021, high- and upper-middle-income countries had administered at least one dose per person on average, compared with one for every three people in lower-middle-income countries and one for every 25 people in low-income countries.
Studies reviewed in the publication estimate that if lower-middle- and low-income countries had matched the roll-out rates of high-income countries, as many as half of their COVID-19 deaths might have been averted by October 2021, and that sharing existing supply more equitably could have prevented 1.3 million deaths worldwide by the end of 2021. Delayed protection in lower-resource settings also prolonged transmission, raised the risk of new variants emerging and slowed economic recovery, weakening health and economic security across borders.
PSI’s Dr Mahan Ghafari, principal author of study, said:
“Effective pandemic preparedness requires clear allocation principles to be agreed before a crisis begins. When vaccine supplies are limited, distribution should respond to epidemiological evidence, including disease burden, risk of severe outcomes and the speed of transmission, so that vaccines reach the places where they can prevent the greatest harm.
“But for millions of people in poorer countries, they still arrived too late. The science moved at record speed while the systems for financing, sharing and delivering vaccines did not. Next time, the rules on who receives vaccines, and when, have to be agreed upon before the outbreak rather than negotiated in the middle of it.”
“COVID-19 proved wrong those who claimed that the virus would treat us all equally”, said Professor Kaveh Madani, Director of UNU-INWEH and a co-author of this publication. “Once again, we saw how a shared global threat can disproportionately harm the poor and less privileged. That experience taught us that we cannot rely on the speed of science and innovation alone. Before the next global emergency strikes, we must strengthen the foundations for equity through cooperative global mechanisms that can effectively improve financing, manufacturing and delivery, ensuring that life-saving solutions reach those who need them most.”
Co-author Dr Kaja Abbas (London School of Hygiene & Tropical Medicine and Nagasaki University), said:
“Embedding equity as a fundamental principle in the discovery, development, and delivery of safe, effective and affordable vaccines within the pandemic preparedness and response plans is key to protecting people from emerging and re-emerging infectious diseases. Access barriers for populations in low-resource settings directly affect them and indirectly affect populations in high-resource settings, and fair and equitable access to vaccines is essential for mitigating the pandemic impact on public health and the global economy.”
PSI's Associate Professor Jasmina Panovska-Griffiths, senior lead on this work, noted:
“In this evidence synthesis piece, we argue that equity-by-design is essential for equitable and fair vaccines allocation and delivery in future outbreaks and pandemics and for improved public health impact.
“Alongside this, improved pandemic preparedness and effective response also hinge on our ability to transform existing and develop new technical tools into reliable, global public goods that protect people in both LMICs and HICs.
“These should include genomic surveillance for early variant detection, standardised data collection and sharing platforms to track in-countries and cross-countries spread, established and robust modelling hubs for scenarios analysis, epidemic projections and to evaluate vaccine impact across diverse contexts, and adaptive trial designs.”
Read the full press release on the UNU-INWEH website.